Get all your news in one place.
100’s of premium titles.
One app.
Start reading
One app.
Get all your news in one place.
100’s of premium titles. One news app.
The Latest Breaking News on After US approval, Japan OKs its first Alzheimer's drug. Leqembi was developed by Eisai and Biogen
From analysis to the latest developments in health,
read the most diverse news in one place.
read the most diverse news in one place.
Read news from The Economist, FT, and more,
with one subscription
with one subscription
Get all your
news in one place.
news in one place.
100’s of premium titles.
One news app.
One news app.
Get all your
news in one place.
news in one place.
100’s of premium titles.
One news app.
One news app.
From analysis to the latest developments in health,
read the most diverse news in one place.
read the most diverse news in one place.
Organisations
FDA
4,555 stories
Eli Lilly
673 stories
Food and Drug Administration
323 stories
CMS
312 stories
Lilly
303 stories
Biogen
275 stories
Medicare
177 stories
Lancet
141 stories
Eisai
99 stories
Biogen Inc
82 stories
US Food and Drug Administration
63 stories
National Institutes of Health
62 stories
Queen Mary University of London
62 stories
New England Journal of Medicine
30 stories
Leqembi
24 stories
Alzheimer Association
19 stories
Aduhelm
15 stories
Read news from The Economist, FT, and more,
with one subscription
with one subscription
Topics